Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R

Biologicals

Volumn 36, Issue 4, 2008, Pages 213-222

  Schegg, Vanessa ^a,d   Vogel, Monique ^a   Didichenko, Svetlana ^a   Stadler, Michael B ^b   Beleznay, Zsuzsanna ^a   Gadola, Stephan ^a   Sengupta, Christine ^c   Stadler, Beda M ^a   Miescher, Sylvia M ^a,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^c Rheumapraxis Sengupta ^*  (Switzerland)

^d CSL Behring AG   (Switzerland)

Author keywords

Anti muscarinic receptor antibodies; Binding assays; Cross reactivity; Intravenous immunoglobulin; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CHO CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CROSS REACTION; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; NEUROTRANSMISSION; NONHUMAN; PEPTIDE SYNTHESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR BINDING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; WESTERN BLOTTING;

ANIMALS; AUTOANTIBODIES; CHO CELLS; CRICETINAE; CRICETULUS; CROSS REACTIONS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN BINDING; RABBITS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M3; SJOGREN'S SYNDROME; TRANSFECTION;

ORYCTOLAGUS CUNICULUS;

EID: 45849104639     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2007.11.001     Document Type: Article

References (40)

1. Bacman S., Sterin-Borda L., Camusso J.J., Arana R., Hubscher O., and Borda E. Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 104 3 (1996) 454-459
2. Gautam D., Heard T.S., Cui Y., Miller G., Bloodworth L., and Wess J. Cholinergic stimulation of salivary secretion studied with M1 and M3 muscarinic receptor single- and double-knockout mice. Mol Pharmacol 66 2 (2004) 260-267
3. Nakamura M., Tada Y., Akaishi T., and Nakata K. M3 muscarinic receptor mediates regulation of protein secretion in rabbit lacrimal gland. Curr Eye Res 16 6 (1997) 614-619
4. Mori K., Iijima M., Koike H., Hattori N., Tanaka F., Watanabe H., et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 128 Pt 11 (2005) 2518-2534
5. Goldblatt F., Gordon T.P., and Waterman S.A. Antibody-mediated gastrointestinal dysmotility in scleroderma. Gastroenterology 123 4 (2002) 1144-1150
6. Wang F., Jackson M.W., Maughan V., Cavill D., Smith A.J., Waterman S.A., et al. Passive transfer of Sjögren's syndrome IgG produces the pathophysiology of overactive bladder. Arthritis Rheum 50 11 (2004) 3637-3645
7. Eftekhari P., Salle L., Lezoualc'h F., Mialet J., Gastineau M., Briand J.P., et al. Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block. Eur J Immunol 30 10 (2000) 2782-2790
8. Bacman S., Perez Leiros C., Sterin-Borda L., Hubscher O., Arana R., and Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci 39 1 (1998) 151-156
9. Reina S., Sterin-Borda L., Orman B., and Borda E. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications. J Neuroimmunol 150 1-2 (2004) 107-115
10. Berra A., Sterin-Borda L., Bacman S., and Borda E. Role of salivary IgA in the pathogenesis of Sjögren syndrome. Clin Immunol 104 1 (2002) 49-57
11. Bacman S., Berra A., Sterin-Borda L., and Borda E. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Invest Ophthalmol Vis Sci 42 2 (2001) 321-327
12. Gao J., Cha S., Jonsson R., Opalko J., and Peck A.B. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 50 8 (2004) 2615-2621
13. Dawson L.J., Allison H.E., Stanbury J., Fitzgerald D., and Smith P.M. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjögren's syndrome using conventional immunological approaches. Rheumatology (Oxford) 43 12 (2004) 1488-1495
14. Waterman S.A., Gordon T.P., and Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 43 7 (2000) 1647-1654
15. Cavill D., Waterman S.A., and Gordon T.P. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome. Scand J Immunol 59 3 (2004) 261-266
16. Dawson L.J., Stanbury J., Venn N., Hasdimir B., Rogers S.N., and Smith P.M. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells. Arthritis Rheum 54 4 (2006) 1165-1173
17. Sterin-Borda L., Goin J.C., Bilder C.R., Iantorno G., Hernando A.C., and Borda E. Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence. Gut 49 5 (2001) 699-705
18. Borda T., Gomez R., Berria M.I., and Sterin-Borda L. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera. Glia 45 2 (2004) 144-154
19. Cavill D., Waterman S.A., and Gordon T.P. Failure to detect antibodies to extracellular loop peptides of the muscarinic M3 receptor in primary Sjögren's syndrome. J Rheumatol 29 6 (2002) 1342-1344
20. Marczinovits I., Kovacs L., Gyorgy A., Toth G.K., Dorgai L., Molnar J., et al. A peptide of human muscarinic acetylcholine receptor 3 is antigenic in primary Sjögren's syndrome. J Autoimmun 24 1 (2005) 47-54
21. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 6 (2002) 554-558
22. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 3 (1988) 315-324
23. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 11 (1982) 1271-1277
24. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23 5 (1980) 581-590
25. Horn F., Weare J., Beukers M.W., Horsch S., Bairoch A., Chen W., et al. GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res 26 1 (1998) 275-279
26. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 15 (1997) 2714-2723
27. Moller S., Croning M.D., and Apweiler R. Evaluation of methods for the prediction of membrane spanning regions. Bioinformatics 17 7 (2001) 646-653
28. Hofmann K., and Stoffel W. TMbase- A database of membrane spanning proteins segments. Biol Chem Hoppe-Seyler 374 (1993) 166
29. Bonner T.I., Young A.C., Brann M.R., and Buckley N.J. Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1 5 (1988) 403-410
30. Buckley N.J., Bonner T.I., Buckley C.M., and Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol Pharmacol 35 4 (1989) 469-476
31. Buckley N.J., Bonner T.I., and Brann M.R. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci 8 12 (1988) 4646-4652
32. Dawson L., Tobin A., Smith P., and Gordon T. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going?. Arthritis Rheum 52 10 (2005) 2984-2995
33. Zigon P., Bozic B., Cucnik S., Rozman B., Tomsic M., Kveder T., et al. Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjögren's syndrome? * Author's reply. Ann Rheum Dis 64 8 (2005) 1247
34. Naito Y., Matsumoto I., Wakamatsu E., Goto D., Sugiyama T., Matsumura R., et al. Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome. Ann Rheum Dis 64 3 (2005) 510-511
35. Gordon T.P., Bolstad A.I., Rischmueller M., Jonsson R., and Waterman S.A. Autoantibodies in primary Sjögren's syndrome: new insights into mechanisms of autoantibody diversification and disease pathogenesis. Autoimmunity 34 2 (2001) 123-132
36. Jonsson R., Moen K., Vestrheim D., and Szodoray P. Current issues in Sjögren's syndrome. Oral Dis 8 3 (2002) 130-140
37. Tobin A.B., and Nahorski S.R. Rapid agonist-mediated phosphorylation of m3-muscarinic receptors revealed by immunoprecipitation. J Biol Chem 268 13 (1993) 9817-9823
38. Yamada M., Miyakawa T., Duttaroy A., Yamanaka A., Moriguchi T., Makita R., et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410 6825 (2001) 207-212
39. Zeng F.Y., Soldner A., Schoneberg T., and Wess J. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for proper receptor cell surface localization but not for G protein coupling. J Neurochem 72 6 (1999) 2404-2414
40. Budd D.C., Rae A., and Tobin A.B. Activation of the mitogen-activated protein kinase pathway by a Gq/11-coupled muscarinic receptor is independent of receptor internalization. J Biol Chem 274 18 (1999) 12355-12360